Evidence map›Paper›PMID 29904387›Full record

ArticleFrontiers in immunology2018

Anti-Lipoarabinomannan-Specific Salivary IgA as Prognostic Marker for Leprosy Reactions in Patients and Cellular Immunity in Contacts.

André Alan Nahas, Mayara Ingrid de Sousa Lima, Isabela Maria Bernardes Goulart, Luiz Ricardo Goulart

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Serum IgA Antibodies Specific toFrontiers in medicine · 2021
    Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

André Alan NahasInstitute of Biotechnology, Federal University of Uberlândia, Uberlândia, MG, Brazil.
Mayara Ingrid de Sousa LimaBiology Department, Federal University of Maranhão, São Luis, MA, Brazil.
Isabela Maria Bernardes GoulartNational Reference Center for Sanitary Dermatology and Leprosy, Clinics' Hospital, School of Medicine, Federal University of Uberlândia, Uberlândia, MG, Brazil.
Luiz Ricardo GoulartInstitute of Biotechnology, Federal University of Uberlândia, Uberlândia, MG, Brazil.
Universidade Federal de Uberlândia · BRUniversidade Federal do Maranhão · BRUniversity of California Davis Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leprosy causes the most common peripheral neuropathy of infectious etiology, posing an important public health problem worldwide. Understanding the molecular and immunological mechanisms of nerve damage induced by

Indexed as

Immunity, CellularAntibodies, BacterialAntibody SpecificityAntigens, BacterialCase-Control StudiesEnzyme-Linked Immunosorbent AssayFemaleHumansImmunoglobulin A, SecretoryImmunoglobulin MLeprosyLipopolysaccharidesMaleMycobacterium lepraeOdds RatioSalivaAntibodies, BacterialAntigens, BacterialImmunoglobulin A, SecretoryImmunoglobulin MlipoarabinomannanLipopolysaccharideshousehold contactsleprosy reactionslipoarabinomannanprognostic markersalivary IgA

Identifiers

PMID29904387
PMCPMC5990868
OpenAlexW2807460452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.